253 related articles for article (PubMed ID: 15486994)
1. Androgen receptor corepressors: an overview.
Wang L; Hsu CL; Chang C
Prostate; 2005 May; 63(2):117-30. PubMed ID: 15486994
[TBL] [Abstract][Full Text] [Related]
2. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
3. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.
Dotzlaw H; Papaioannou M; Moehren U; Claessens F; Baniahmad A
Mol Cell Endocrinol; 2003 Dec; 213(1):79-85. PubMed ID: 15062576
[TBL] [Abstract][Full Text] [Related]
4. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
6. A zinc finger protein TZF is a novel corepressor of androgen receptor.
Ishizuka M; Kawate H; Takayanagi R; Ohshima H; Tao RH; Hagiwara H
Biochem Biophys Res Commun; 2005 Jun; 331(4):1025-31. PubMed ID: 15882980
[TBL] [Abstract][Full Text] [Related]
7. Corepressor recruitment by agonist-bound nuclear receptors.
White JH; Fernandes I; Mader S; Yang XJ
Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
[TBL] [Abstract][Full Text] [Related]
8. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
9. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor coregulators: recruitment via the coactivator binding groove.
van de Wijngaart DJ; Dubbink HJ; van Royen ME; Trapman J; Jenster G
Mol Cell Endocrinol; 2012 Apr; 352(1-2):57-69. PubMed ID: 21871527
[TBL] [Abstract][Full Text] [Related]
11. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Yuan H; Gong A; Young CY
Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
[TBL] [Abstract][Full Text] [Related]
12. Cloning and functional characterization of a rat Daxx that functions as a corepressor for the androgen receptor.
Mizuta H; Kuroda Y
Cell Biol Int; 2004; 28(8-9):609-14. PubMed ID: 15350595
[TBL] [Abstract][Full Text] [Related]
13. [Androgen--biosynthesis, receptor and action].
Shiina H; Igawa M
Nihon Rinsho; 1997 Nov; 55(11):2860-4. PubMed ID: 9396277
[TBL] [Abstract][Full Text] [Related]
14. In vitro regulation of reporter gene transcription by the androgen receptor AF1 domain.
Choudhry MA; McEwan IJ
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1103-6. PubMed ID: 15506979
[TBL] [Abstract][Full Text] [Related]
15. ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor.
Harada N; Ohmori Y; Yamaji R; Higashimura Y; Okamoto K; Isohashi F; Nakano Y; Inui H
Biochem Biophys Res Commun; 2008 Aug; 373(3):373-7. PubMed ID: 18565325
[TBL] [Abstract][Full Text] [Related]
16. Genetic regulation of androgen action.
Kallio PJ; Pakvimo JJ; Janne OA
Prostate Suppl; 1996; 6():45-51. PubMed ID: 8630229
[TBL] [Abstract][Full Text] [Related]
17. ZIP kinase plays a crucial role in androgen receptor-mediated transcription.
Leister P; Felten A; Chasan AI; Scheidtmann KH
Oncogene; 2008 May; 27(23):3292-300. PubMed ID: 18084323
[TBL] [Abstract][Full Text] [Related]
18. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor repression: regulatory mechanisms and physiological implications.
Stewart MD; Wong J
Prog Mol Biol Transl Sci; 2009; 87():235-59. PubMed ID: 20374706
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics.
Chen G; Wang X; Zhang S; Lu Y; Sun Y; Zhang J; Li Z; Lu J
Prostate; 2005 Jun; 63(4):395-406. PubMed ID: 15617028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
